The Army Combat Fitness Test (ACFT) and the health of the active component: Understanding the link between the ACFT and personnel health and injuries

Abstract: The Army Combat Fitness Test (ACFT) became the U.S. Army's physical fitness test of record in October 2022. The test is substantially different from the previous test and consists of six events intended to measure a more expansive set of capabilities: muscular strength and endurance, power, speed, agility, aerobic endurance, balance, flexibility, coordination, and reaction time. One of the Army's stated goals for the test was to reduce preventable injuries. More than half of soldiers experienced a new injury in 2021, so success in reducing the risk of injury could have a significant impact on both medical costs and lost workdays. Because the ACFT has been administered for a relatively short period, there are limited data available to assess the relationship between the ACFT and soldier health and injuries. Nevertheless, this research effort used available data to gain initial insights into this relationship. This study was part of RAND's independent assessment of the ACFT, focusing specifically on injury risk. To the extent that broader, more-holistic training is motivated by the more-expansive physical requirements of the ACFT, the literature suggests that the ACFT could in the long term lead to an overall reduction in injury rates. Many of the authors' recommendations focus on potential ACFT policy actions that the Army could take to help reduce preventable injuries and assess and monitor soldiers at risk.

Read the full article
Report a problem with this article

Related articles

  • More for Policy & Practice

    Temporal trends in opioid-related care and pain among Veterans at the end of life

    Abstract: Context: In response to the opioid crisis, federal guidelines were implemented, including the Veterans Health Administration's (VA) Opioid Safety Initiative in 2013. The impact of policies on patients near the end of life is unknown. Objective: Examine temporal trends in opioid prescribing, pain, and opioid overdoses among Veterans near the end of life. Methods: Retrospective, time series analysis of VA decedents between October 2009 and September 2018 whose next-of-kin participated in VA's Bereaved Family Survey (BFS). Using multivariate regression to adjust for sociodemographic and clinical covariates, we examined temporal trends in outpatient opioid prescribing, uncontrolled pain based on BFS report, and opioid overdose-related hospitalizations, in the last month of life, overall and by clinical diagnosis (cancer versus non-cancer). Results: Among 79,409 decedents, mean daily outpatient opioid dose in morphine milligram equivalents in the last month of life decreased from 4.6 mg in 2010 to 2.1 mg in 2018 (adjusted change -0.20 mg/year; P